AmSpa vendor partner, Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, and Allergan plc, (NYSE: AGN) a leading global pharmaceutical company, today announced a collaboration to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan's healthcare provider loyalty program, Allergan Partner Privileges® (APP®). "This partnership brings together two very strong aesthetics product portfolios to provide physicians and their patients with comprehensive treatment options for some of the most in demand treatments, including body contouring and skin treatment," said Amit Meridor, Chief Executive Officer of Syneron Medical. "We are excited to partner with Allergan to introduce our products to Allergan's community of aesthetic healthcare providers and their patients. In addition, at a strategic level, this partnership will enhance our ability to build stronger relationships with our customers, supported by a full product solution offering." Effective immediately, all members of APP® will receive discounted pricing on Syneron's UltraShape and VelaShape III platforms for body contouring and the PicoWay platform for skin treatment. The companies also plan to launch an additional consumer program later this year. "This partnership allows us to offer our Allergan Partner Privileges® members a special offering on Syneron Candela's innovative aesthetic products, specifically, their VelaShape III and UltraShape body sculpting platforms," said Philippe Schaison, EVP and President Allergan Medical. "This collaboration complements our existing portfolio of industry-leading aesthetic products and further demonstrates Allergan's commitment to providing our customers with a robust portfolio of treatments designed to better address their evolving patient needs."